Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 8,065-8,076 of 10,592
Drug study icon
CompletedNCT04188392

Pimavanserin for Insomnia In Veterans With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States
Sponsor
Baylor College of Medicine
Condition
PTSD
Drug study icon
WithdrawnNCT05796167

Pimavanserin for Sleep in Parkinson Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 40 Years to 85 Years
Countries
United States
Sponsor
State University of New York - Downstate Medical Center
Condition
Schizophrenia
Drug study icon
CompletedNCT01342380

Pioglitazone and Quetiapine XR Pharmacogenetic Study

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

Remote / online
Depression, BipolarityOtherFrom 18 Years to 70 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Depression, Bipolarity
Drug study icon
TerminatedNCT01395797

Pioglitazone for Heroin and for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 55 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Addiction
Behavioral study icon
CompletedNCT03864146

Pioglitazone for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Addiction
Behavioral study icon
CompletedNCT00835120

Pioglitazone for Bipolarity and Comorbid Metabolic Syndrome or Insulin Resistance

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

In United States
Bipolarity, DepressionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity, Depression
Drug study icon
TerminatedNCT01717040

Pioglitazone for Depression in bipolarity

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

In United States
Bipolarity, DepressionDrugOver 18 Years
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00000198

Piracetam for Treatment of Cocaine Addiction - 3

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 45 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.